Becker's Healthcare August 29, 2024
Over the past 18 months, healthtech investment volume has decreased as investors have endured inflation, elevated interest rates and greater uncertainty, Deloitte said in an Aug. 27 report.
Healthtech investors have shifted their strategies and priorities during this span, according to the report. Investors are now prioritizing proven business models that have a “demonstrated track record of healthy liquidity and sustainable revenue and profit.”
Deloitte said revenue cycle...
Today's Sponsors
Today's Sponsor